Rathbones Group PLC Buys Shares of 3,883 SPDR S&P Biotech ETF $XBI

Rathbones Group PLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,883 shares of the exchange traded fund’s stock, valued at approximately $473,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of XBI. AdvisorNet Financial Inc grew its holdings in shares of SPDR S&P Biotech ETF by 7.3% in the 3rd quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after purchasing an additional 100 shares during the last quarter. Moors & Cabot Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 3.8% in the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after purchasing an additional 100 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.1% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock worth $340,000 after purchasing an additional 101 shares during the last quarter. Kingsview Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 1.8% in the 3rd quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock worth $582,000 after purchasing an additional 103 shares during the last quarter. Finally, Certuity LLC grew its holdings in shares of SPDR S&P Biotech ETF by 1.4% in the 3rd quarter. Certuity LLC now owns 10,374 shares of the exchange traded fund’s stock worth $1,039,000 after purchasing an additional 144 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $130.65 on Thursday. The firm’s 50-day simple moving average is $125.11 and its 200-day simple moving average is $119.10. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $133.27. The firm has a market cap of $7.96 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.